Cindy S. Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cindy S. Lee has a total of 247 co-authors. Here are the top co-authors by number of shared publications:
Edward A. Sickles
10 shared publications- Linda Moy
Department of Radiology, New York University School of Medicine, New York, NY
9 shared publications - Alexander Noor Shoushtari
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
8 shared publications - Amanda R. Moore
Department of Research Oncology, Genentech, South San Francisco, USA
8 shared publications - Barry S. Taylor
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
8 shared publications - Emilie Ceraudo
Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York
8 shared publications
Latest Publications
- 1 November 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (2) , e243918
Identification of Risk Factors for Interval Breast Cancer in a Population-based Screening Program
In an analysis of mammograms from a population-based screening program, high breast density, family history of breast cancer, and suboptimal radiologist interpretative screening performance were found to be associated with an increased risk of interval breast cancer.
- 1 November 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (2) , e243918
Identification of Risk Factors for Interval Breast Cancer in a Population-based Screening Program
In an analysis of mammograms from a population-based screening program, high breast density, family history of breast cancer, and suboptimal radiologist interpretative screening performance were found to be associated with an increased risk of interval breast cancer.
- 28 October 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 203 (3) , 599-612
Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women
Purpose There are insufficient large-scale studies comparing the performance of screening mammography in women of different races. This study aims to compare the screening performance metrics across racial and age groups in the National Mammography Database (NMD). Methods All screening mammograms performed between January 1, 2008, and December 31, 2021, in women aged 30–100 years from 746 mammography facilities in 46 U.S. states in the NMD were included. Patients were stratified by 10-year age intervals and 5 racial groups (African American, American Indian, Asian, White, unknown). Incidence of risk factors (breast density, personal history, family history of breast cancer, age), and time since prior exams were compared. Five screening mammography metrics were calculated: recall rate (RR), cancer detection rate (CDR), positive predictive values for recalls (PPV1), biopsy recommended (PPV2) and biopsy performed (PPV3). Results 29,479,655 screening mammograms performed in 13,181,241 women between January 1, 2008, and December 31, 2021, from the NMD were analyzed. The overall mean performance metrics were RR 10.00% (95% CI 9.99–10.02), CDR 4.18/1000 (4.16–4.21), PPV1 4.18% (4.16–4.20), PPV2 25.84% (25.72–25.97), PPV3 25.78% (25.66–25.91). With advancing age, RR significantly decreases, while CDR, PPV1, PPV2, and PPV3 significantly increase. Incidence of personal/family history of breast cancer, breast density, age, prior mammogram availability, and time since prior mammogram were mostly similar across all races. Compared to White women, African American women had significantly higher RR, but lower CDR, PPV1, PPV2 and PPV3. Conclusions Benefits of screening mammography increase with age, including for women age > 70 and across all races. Screening mammography is effective; with lower RR and higher CDR, PPV2, and PPV3 with advancing age. African American women have poorer outcomes from screening mammography (higher RR and lower CDR), compared to White and all women in the NMD. Racial disparity can be partly explained by higher rate of African American women lost to follow up.
- 28 October 2023
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 203 (3) , 599-612
Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women
Purpose There are insufficient large-scale studies comparing the performance of screening mammography in women of different races. This study aims to compare the screening performance metrics across racial and age groups in the National Mammography Database (NMD). Methods All screening mammograms performed between January 1, 2008, and December 31, 2021, in women aged 30–100 years from 746 mammography facilities in 46 U.S. states in the NMD were included. Patients were stratified by 10-year age intervals and 5 racial groups (African American, American Indian, Asian, White, unknown). Incidence of risk factors (breast density, personal history, family history of breast cancer, age), and time since prior exams were compared. Five screening mammography metrics were calculated: recall rate (RR), cancer detection rate (CDR), positive predictive values for recalls (PPV1), biopsy recommended (PPV2) and biopsy performed (PPV3). Results 29,479,655 screening mammograms performed in 13,181,241 women between January 1, 2008, and December 31, 2021, from the NMD were analyzed. The overall mean performance metrics were RR 10.00% (95% CI 9.99–10.02), CDR 4.18/1000 (4.16–4.21), PPV1 4.18% (4.16–4.20), PPV2 25.84% (25.72–25.97), PPV3 25.78% (25.66–25.91). With advancing age, RR significantly decreases, while CDR, PPV1, PPV2, and PPV3 significantly increase. Incidence of personal/family history of breast cancer, breast density, age, prior mammogram availability, and time since prior mammogram were mostly similar across all races. Compared to White women, African American women had significantly higher RR, but lower CDR, PPV1, PPV2 and PPV3. Conclusions Benefits of screening mammography increase with age, including for women age > 70 and across all races. Screening mammography is effective; with lower RR and higher CDR, PPV2, and PPV3 with advancing age. African American women have poorer outcomes from screening mammography (higher RR and lower CDR), compared to White and all women in the NMD. Racial disparity can be partly explained by higher rate of African American women lost to follow up.
- 1 May 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (5) , e220166
Women 75 Years Old or Older: To Screen or Not to Screen?
Breast cancer is the most common cancer in women, with the incidence rising substantially with age. Older women are a vulnerable population at increased risk of developing and dying from breast cancer. However, women aged 75 years and older were excluded from all randomized controlled screening trials, so the best available data regarding screening benefits and risks in this age group are from observational studies and modeling predictions. Benefits of screening in older women are the same as those in younger women: early detection of smaller lower-stage cancers, resulting in less invasive treatment and lower morbidity and mortality. Mammography performs significantly better in older women with higher sensitivity, specificity, cancer detection rate, and positive predictive values, accompanied by lower recall rates and false positives. The overdiagnosis rate is low, with benefits outweighing risks until age 90 years. Although there are conflicting national and international guidelines about whether to continue screening mammography in women beyond age 74 years, clinicians can use shared decision making to help women make decisions about screening and fully engage them in the screening process. For women aged 75 years and older in good health, continuing annual screening mammography will save the most lives. An informed discussion of the benefits and risks of screening mammography in older women needs to include each woman's individual values, overall health status, and comorbidities. This article will review the benefits, risks, and controversies surrounding screening mammography in women 75 years old and older and compare the current recommendations for screening this population from national and international professional organizations. ©RSNA, 2023 Quiz questions for this article are available through the Online Learning Center.
- 1 May 2023
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 43 (5) , e220166
Women 75 Years Old or Older: To Screen or Not to Screen?
Breast cancer is the most common cancer in women, with the incidence rising substantially with age. Older women are a vulnerable population at increased risk of developing and dying from breast cancer. However, women aged 75 years and older were excluded from all randomized controlled screening trials, so the best available data regarding screening benefits and risks in this age group are from observational studies and modeling predictions. Benefits of screening in older women are the same as those in younger women: early detection of smaller lower-stage cancers, resulting in less invasive treatment and lower morbidity and mortality. Mammography performs significantly better in older women with higher sensitivity, specificity, cancer detection rate, and positive predictive values, accompanied by lower recall rates and false positives. The overdiagnosis rate is low, with benefits outweighing risks until age 90 years. Although there are conflicting national and international guidelines about whether to continue screening mammography in women beyond age 74 years, clinicians can use shared decision making to help women make decisions about screening and fully engage them in the screening process. For women aged 75 years and older in good health, continuing annual screening mammography will save the most lives. An informed discussion of the benefits and risks of screening mammography in older women needs to include each woman's individual values, overall health status, and comorbidities. This article will review the benefits, risks, and controversies surrounding screening mammography in women 75 years old and older and compare the current recommendations for screening this population from national and international professional organizations. ©RSNA, 2023 Quiz questions for this article are available through the Online Learning Center.
- 1 May 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (4) , e230505
New Screening Performance Metrics for Digital Breast Tomosynthesis in U.S. Community Practice from the Breast Cancer Surveillance Consortium
- 1 May 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (4) , e230505
New Screening Performance Metrics for Digital Breast Tomosynthesis in U.S. Community Practice from the Breast Cancer Surveillance Consortium
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S6 from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Supplementary figures S1-S6 with figure legends.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S6 from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
Supplementary figures S1-S6 with figure legends.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Combined Inhibition of Gαq and MEK Enhances Therapeutic Efficacy in Uveal Melanoma